Annual Drug Patent Expirations for VABOMERE Vabomere is a drug marketed by Rempex Pharms and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Rempex Pharms drug VABOMERE appeared first on DrugPa…
Annual Drug Patent Expirations for QBRELIS Qbrelis is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Azurity drug QBRELIS appeared first on DrugPatentW…
Annual Drug Patent Expirations for SAVAYSA Savaysa is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Daiichi Sankyo drug SAVAYSA appeared first on DrugPatentWa…
Annual Drug Patent Expirations for FORTAMET Fortamet is a drug marketed by Andrx Labs Llc and is included in one NDA. It is available from two suppliers. There are two…
The post New patent expiration for Andrx Labs drug FORTAMET appeared first on DrugP…
New patent expiration for Andrx Labs drug FORTAMET Read Post »
Annual Drug Patent Expirations for ACTOPLUS+MET+XR Actoplus Met Xr is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Takeda Pharms drug ACTOPLUS MET XR appea…
New patent expiration for Takeda Pharms drug ACTOPLUS MET XR Read Post »
This chart shows the pharmaceutical companies with the most patents in Poland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Poland? Read Post »
Annual Drug Patent Expirations for WAKIX Wakix is a drug marketed by Harmony and is included in one NDA. There are five patents protecting this drug. This drug has seventy-three…
The post New patent for Harmony drug WAKIX appeared first on DrugPatentWa…
Annual Drug Patent Expirations for VESICARE+LS Vesicare Ls is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Astellas drug VESICARE LS appeared first on Drug…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Finland? Read Post »
TWIRLA (ethinyl estradiol; levonorgestrel) Agile Patent: 7,045,145 Expiration: Mar 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The pos…
Drug Patent Expirations for the Week of March 14, 2021 Read Post »
Get new actionable insights and updates from BiotechBlog
